SCHEMBL4150001

SCHEMBL4150001

CSCCNC(=O)N(C)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTPRZ1 P23471 1/20 0.34
EPHX2 P34913 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
ALOX5 P09917 1/20 0.32
MCHR1 Q99705 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
TSHR P16473 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4149965 0.87 ACKR3 (0.38) MAPK1SMN1; SMN2PTPRZ1EPHX2NR1H4
SCHEMBL4142022 0.85 PTPRZ1 (0.37) MAPK1SMN1; SMN2PTPRZ1EPHX2NR1H4
SCHEMBL13774526 0.85 MCHR1 (0.37) NPC1RAB9ATP53HPGDSMN1; SMN2
SCHEMBL4150851 0.84 PTPRZ1 (0.36) MAPK1L3MBTL1PTPRZ1EPHX2NR1H4
SCHEMBL5314377 0.84 MCHR1 (0.33) MAPK1NPC1RAB9ATP53HPGD
SCHEMBL4144820 0.82 PTPRZ1 (0.35) MAPK1SMN1; SMN2PTPRZ1EPHX2NR1H4
SCHEMBL4149940 0.82 PTPRZ1 (0.35) MAPK1PTPRZ1EPHX2NR1H4MCHR1
SCHEMBL14546325 0.82 PDK2 (0.39) MAPK1NPC1RAB9ATP53HPGD
SCHEMBL4146959 0.81 L3MBTL1 (0.35) HPGDL3MBTL1PTPRZ1EPHX2NR1H4
SCHEMBL4149723 0.81 TSHR (0.38) MAPK1PTPRZ1EPHX2NR1H4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MAPK1 973/4885NPC1 1869/4885RAB9A 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.